Phoslo (Calcium Acetate) - Current Clinical Trials

Phoslo Related Clinical Trials

CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients [Completed]

EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) [Completed]

Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4 [Recruiting]

Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers [Recruiting]

Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate [Not yet recruiting]

Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction [Recruiting]

Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients [Recruiting]

Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis [Completed]

A 58-Week Safety and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-stage Renal Disease (ESRD) on Dialysis [Not yet recruiting]

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD [Recruiting]

Phosphate Kinetic Modeling [Recruiting]

Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals [Completed]

Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD [Completed]

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease [Recruiting]